Skip to main content

Table 3 Ability of miniaturized echocardiographic system to diagnose clinical problems in a population of 151 patients

From: Evaluation of a new pocket echoscopic device for focused cardiac ultrasonography in an emergency setting

 

Number of patients

Se, percentage (95% CI)

Sp, percentage (95% CI)

PPV, percentage (95% CI)

NPV, percentage (95% CI)

κ (95% CI)

Left ventricle

      

   Left ventricular ejection fraction < 50%

28

86 (69-94)

99 (96-100)

96 (80-99)

97 (93-99)

0.89 (0.79-0.98)

   Left ventricular dilation

8

94 (61-99)

96 (91-98)

57 (32-79)

100 (97-100)

0.70 (0.48-0.93)

   Left ventricular hypertrophy

26

77 (58-89)

97 (92-99)

83 (64-93)

95 (90-98)

0.76 (0.62-0.90)

Right ventricle

      

   Right ventricular dilation, cutoff of 0.6

21

59 (39-77)

98 (94-99)

87 (62-96)

93 (87-96)

0.66 (0.47-0.85)

   Severe right ventricular dilation, cutoff of 1

12

92 (65-98)

99 (95-100)

85 (59-96)

99 (96-100)

0.87 (0.72-1)

Pericardum

      

   Pericardial effusion

11

91 (62-89)

96 (92-98)

67 (42-85)

99 (96-100)

0.75 (0.55-0.95)

   Compressive pericardial effusion

2

100 (34-100)

100 (97-100)

100 (34-100)

100 (97-100)

1 (1-1)

Inferior vena cava (IVC)

      

   IVC dilation

20

85 (64-96)

100 (97-100)

97 (78-100)

98 (93-99)

0.90 (0.80-1.00)

   Respiratory variations of IVC size in SB patients

61

97 (89-99)

87 (67-95)

95 (87-98)

91 (71-97)

0.84 (0.71-0.98)

  1. κ, kappa coefficient; CI, confidence interval; NPV, negative predictive value; PPV, positive predictive value; SB, spontaneously breathing; Se, sensitivity; Sp, specificity.